JFI Medical COVID-19 Registration

Rapid and NAAT Tests (Examples of NAAT are PCR & NEAR) are available at the JFI Medical Testing Suite at the Indianapolis Airport located in the Baggage Claim Area between Carousels 2 and 3.

 

Tests are also available through pre-registration by hitting the submit button below or, if one of the three tests options does not fit your needs, you can walk-in on a first-come, first-served basis and get a test result within 3 hours for $300.00  Travelers must verify the type of test required for each trip with their airline and destination. 




                                                             
 






















Type of Test 

RT - PCR (Rapid Polymerase Chain Reaction ) Test             

Results By:     Next Day between 2pm and 5PM.  Except on Saturdays where test results are posted
                              after 2PM on Monday and before 5pm.


Price :    $185.00    
Type of Test                                                              
Accula PCR Rapid Nucleic Acid Amplification Test (NAAT-NEAR)  
Results By:      Same Day Results by 10PM
Price:   $155.00   
Click HERE to learn more about molecular testing
Type of Test                                                              
Rapid Antigen
Results By:     Within 2 hours
Price:     $105.00    
JFI Now Offers Onsite Testing For:

- Corporate Employers 
- Hotels
- Private Events

The Center for Disease Control (CDC) offers additional guidance for travelling during the pandemic. For International travel, please refer to the U.S. State Department’s corona virus resources.

 

What types of SARS-CoV-2 test are acceptable under the Order?

Passengers must be tested with a viral test that could be either an antigen test or a nucleic acid amplification test (NAAT). Examples of available NAATs for SARS-CoV-2 include but are not restricted to reverse transcription polymerase chain reaction (RT-PCR), reverse transcription loop-mediated isothermal amplification (RT-LAMP), transcription-mediated amplification (TMA), nicking enzyme amplification reaction (NEAR), and helicase-dependent amplification (HDA). The test used must be authorized for use by the relevant national authority for the detection of SARS-CoV-2 in the country where the test is administered. A viral test conducted for U.S. Department of Defense (DOD) personnel, including DOD contractors, dependents, and other U.S. government employees, and tested by a DOD laboratory located in a foreign country also meets the requirements of the Order